Multiple Sclerosis Research FAQs Contact
Myelin Repair Foundation — Collaboration. Acceleration. Results.
Home About Us Research Model Myelin Repair News Join Us Donate
Press Archive

We welcome your media-related inquiries. Please contact Carol Menaker via email at carol@myelinrepair.org or by phone at 408-871-2410.

 

Articles and press coverage:

The New Yorker -  January 28, 2008 – Buying a Cure

We Are the New Radicals: A Manifesto for Reinventing Yourself and Saving the World features MRF President Scott Johnson as one of several "boomers" who has leveraged his career expertise to take on some of the world's toughest problems.

BusinessWeek -  November 2007 – Software that maps who is working on common problems is shaving years off research—and honing corporate strategies.

Dick Gordon, host of American Public Media's The Story, interviews Scott Johson about his MS diagnosis and the need for a new model that will speed the delivery of patient treatments for all diseases. Listen here.

Scientific American Podcast - Scott Johnson tells listeners about MRF's Accelerated Research Collaboration model. Listen here.

Fast Company magazine's FAST 50 - March 2007 issue. MRF named as one of 50 "imaginative, entrepreneurial 'businesses'" who are stepping up to change the world.

In Vivo: The Business & Medicine Report - January 2007 - Peter Lawyer, Senior Vice Predient in the Boston Consulting Group features MRF as a best-in-class model for time-based discovery.

Wall Street Journal: "Why Non-Profits Fund For-Profit Researchers" - January 26, 2007. MRF COO Rusty Bromley comments on the need to "de-risk" drug targets for pharmaceutical companies.

Annals of Neurology: Vol 60 No 6 December 2006: Editors S. Claiborne Johnson, MD, PhD and Stephen L. Hauser, MD, report on the need for new models that will efficiently bridge the gaps between academia, industry and patient treatments.

Genome Biology: December 2006 - A model worth considering is a commentary by Dr. Gregory A. Petsko, Professor of Biochemistry and Chemistry Protein Crystallography at Brandies University.

The Culture of Collaboration: Evan Rosen features the Myelin Repair Foundation's collaborative model along with best practices from Toyota, Proctor & Gamble, Dream Works and others in what Rosen called the "deserialization" of interaction and work.

In The Definitive Drucker, strategic consultant Elizabeth Haas Edershein presents MRF through the eyes of business management icon Peter Drucker in this latest "biography" of his ideas. [Chapter Four: Collaboration and Orchestration]

Scientific American names Scott Johnson among top 50 worldwide for leadership in science, business and policy innovations.

California Gains Science and Tech Praise – November 6, 2006. KCBS-Radio News reports on Scientific American magazine's salute to Scott Johnson as one of 50 worldwide research, business and policy leaders. Listen here.

Fortune Magazine: "One Man's Crusade for a Cure" – September 18, 2006. Fortune magazine profiles MRF founder and President Scott Johnson.

Biotechnology Focus: "Head Rush" – August 23, 2006. MRF COO Rusty Bromley describes MRF's strategy and how it is speeding myelin repair discoveries in this August cover story.

San Jose Mercury News: "Researchers Striving for Good of Humanity and Not Just Own Gain" – July 17, 2006. MRF founder and President Scott Johnson describes in a guest column how traditional medical research needs a face-lift.

San Francisco Chronicle: "Breathing Life into Financing Research" – April 30, 2006. MRF's business-like strategy brings medical scientists together.

Business 2.0: "Raising the Profile of Medical Research" – April 20, 2006. With entrepreneur Scott Johnson at its helm, the Myelin Repair Foundation is pursuing a multiple sclerosis research with all the gusto of a startup.

CBC RadioOne – February 2, 2006. MRF founder and President Scott Johnson is interviewed on CBC Radio One. (Note: Scroll to bottom of CBC page to see MRF story and audio link).

Wall Street Journal: "In Switch, Scientists Share Data to Develop Useful Drug Therapies" – January 20, 2006. The collaborative work between MRF Principal Investigators and the progress that's being made.

ePanorama Magazine Highlights MRF founder and President Scott Johnson – June, 2005
(don’t have correct PDF yet)

McGill Reporter: "Solving the Myelin Mystery" – April 14, 2005

BusinessWeek: "The Patient Leading an Assault on MS" – March 25, 2005

Comcast Cable: Interview with MRF founder and President Scott Johnson – February, 2005

Lincolnshire Review: "A Simple Wish: To Walk Magnificent Mile" – December 9, 2004

SF Bay Area TV station KRON: Report on the Myelin Repair Foundation – November 24, 2004

Wall Street Journal: "Research Push: Anxious for Cures, Grant Givers Turn More Demanding" – September 29, 2004

Silicon Valley Biz Ink: "From Diagnosis to Quest" – February 6, 2004

Silicon Valley Biz Ink: "Non-profits are a New Biotech Breed" – January 23, 2004

TEC Express: "Non-Profit Seeks to Revolutionize Way Science Helps Find Cures, Treatment" – October 28, 2003

ePanorama Magazine: "In His Life and in His Lifetime" – November 1, 2002

 

 
- Back to top -

Press releases :

Myelin Repair Foundation Appoints Vice President of Drug Discovery – January 31, 2007

Scientific American Names Scott Johnson Among Top 50 Worldwide for Innovations in Multiple Sclerosis Research – November 6, 2006

Myelin Repair Foundation Receives $1.2 Million Grant from Robert Wood Johnson Foundation to Further Accelerated Scientific Research Model – September 21, 2005

Myelin Repair Foundation Raises First $5 Million: Omidyar Network Caps First Round Funding – July 18, 2005

Scientists Identify Molecular "Switches" Affecting Myelin Repair in Multiple Sclerosis – June 14, 2005

Myelin Repair Foundation Announces $250,000 Research Award from Biogen Idec – January 31, 2005

Myelin Repair Foundation Selects Scientific Software ECM to Accelerate Multiple Sclerosis Collaboration – December 6, 2004

Intuit Co-Founder Gives $1 Million to Accelerate Scientific Discovery – March 31, 2004

Collaborative Research Initiative Aims to Cut Drug Development Time in Half – January 20, 2004

 

 
- Back to top -

1-877-ToFixMS (1-877-863-4967)

 

Overview
President's Message
Vision and Mission
Management Team
Principal Investigators
Board and Advisors
FAQs
Contact Us
Overview
Accelerated Research Collaboration (ARC™)
ARC™ vs. Traditional Research
Overview
Research Results
Research Plan
Publications
Principal Investigators
Scientific Advisory Board
Newsroom and Resources
New Archive
Research Report Archive
White Papers Archive
Overview
Register
Tell a Friend
Ways to Donate
Tell a Friend